DENTSPLY SIRONA - XRAY Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" XRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View XRAY analyst ratings or view top-rated stocks.

8 brokerages have issued 12-month target prices for DENTSPLY SIRONA's stock. Their XRAY share price forecasts range from $32.00 to $49.00. On average, they anticipate the company's stock price to reach $39.33 in the next year. This suggests a possible upside of 4.8% from the stock's current price.
View analysts price targets for XRAY or view top-rated stocks among Wall Street analysts.

DENTSPLY SIRONA's stock was trading at $31.84 at the start of the year. Since then, XRAY stock has increased by 17.9% and is now trading at $37.53.
View the best growth stocks for 2023 here.

DENTSPLY SIRONA saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 11,700,000 shares, an increase of 29.3% from the February 28th total of 9,050,000 shares. Based on an average trading volume of 2,070,000 shares, the short-interest ratio is currently 5.7 days. Currently, 5.5% of the company's stock are sold short.
View DENTSPLY SIRONA's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our XRAY earnings forecast.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) posted its earnings results on Tuesday, February, 28th. The medical instruments supplier reported $0.46 EPS for the quarter, topping the consensus estimate of $0.32 by $0.14. The medical instruments supplier had revenue of $983 million for the quarter, compared to the consensus estimate of $939.11 million. DENTSPLY SIRONA had a positive trailing twelve-month return on equity of 8.71% and a negative net margin of 24.35%. The firm's revenue was down 10.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.76 EPS.
Read the conference call transcript.

DENTSPLY SIRONA announced a quarterly dividend on Tuesday, February 28th. Shareholders of record on Friday, March 31st will be paid a dividend of $0.125 per share on Friday, April 14th. This represents a $0.50 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Thursday, March 30th.
Read our dividend analysis for XRAY.

ETFs with the largest weight of DENTSPLY SIRONA (NASDAQ:XRAY) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P 500 Equal Weight Health Care ETF (RYH), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), SPDR S&P Health Care Equipment ETF (XHE), First Trust Mid Cap US Equity Select ETF (RNMC), Distillate Small/Mid Cash Flow ETF (DSMC), Invesco Nasdaq Future Gen 200 ETF (QQQS) and First Trust Active Factor Mid Cap ETF (AFMC).

DENTSPLY SIRONA (NASDAQ:XRAY) pays an annual dividend of $0.56 per share and currently has a dividend yield of 1.36%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 25.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, XRAY will have a dividend payout ratio of 25.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for XRAY.

DENTSPLY SIRONA updated its FY23 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of $1.80-2.00 for the period, compared to the consensus estimate of $1.86. The company issued revenue guidance of $3.85-3.95 billion, compared to the consensus revenue estimate of $3.81 billion.

105 employees have rated DENTSPLY SIRONA Chief Executive Officer Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA's stock is owned by many different institutional and retail investors. Top institutional shareholders include Artisan Partners Limited Partnership (6.32%), Nuance Investments LLC (5.88%), First Eagle Investment Management LLC (4.53%), Morgan Stanley (4.04%), Price T Rowe Associates Inc. MD (3.06%) and Cooke & Bieler LP (2.73%). Insiders that own company stock include Cord Friedrich Staehler, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Lisa Yankie, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XRAY stock can currently be purchased for approximately $37.53.

DENTSPLY SIRONA (NASDAQ:XRAY) has a market capitalization of $8.08 billion and generates $3.92 billion in revenue each year. The medical instruments supplier earns $-950,000,000.00 in net income (profit) each year or $2.23 on an earnings per share basis.

The company employs 15,000 workers across the globe.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The official website for the company is www.dentsplysirona.com. The medical instruments supplier can be reached via phone at (844) 848-0137, via email at john.sweeney@dentsplysirona.com, or via fax at 302-655-5049.